Activation of Wiskott-Aldrich syndrome protein and its association with other proteins by stromal cell-derived factor-1alpha is associated with cell migration in a T-lymphocyte line

Exp Hematol. 2002 Jul;30(7):761-6. doi: 10.1016/s0301-472x(02)00823-8.

Abstract

Objectives: Chemokines play a central role in lymphocyte trafficking and homing. The actin cytoskeleton is involved in cell morphological changes and motility. Wiskott-Aldrich syndrome (WAS) protein (WASP) has been implicated in regulation of cytoskeleton rearrangement. To evaluate mechanisms that might be involved in migration of T cells, we examined effects of stromal cell-derived factor (SDF)-1alpha on WASP and associated proteins.

Methods: Jurkat T cells were stimulated by SDF-1alpha and analyzed for chemotaxis and also by Western blot analysis for signal transduction.

Results: Jurkat T cells displayed chemotaxis to SDF-1alpha, which was inhibited by pretreatment of cells with either pertussis toxin, a Galphai protein inhibitor, wortmannin or Ly294002, phophatidylinositol 3-kinase inhibitors, or herbimycin, a protein tyrosine kinase inhibitor. WASP was tyrosine phosphorylated in response to SDF-1alpha stimulation in Jurkat T cells. Crk associated substrate (Cas), Nck, and focal adhesion kinase (FAK) were also phosphorylated after SDF-1alpha stimulation. Moreover, activated Nck interacted with Cas and WASP as determined by co-immunoprecipitation, and FAK also bound to Cas.

Conclusions: These data suggest that WASP, Cas, Nck, and FAK may play a role in SDF-1alpha-induced migration of the T-cell line, Jurkat.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Adaptor Proteins, Signal Transducing
  • Biopolymers
  • Chemokine CXCL12
  • Chemokines, CXC / pharmacology
  • Chemokines, CXC / physiology*
  • Chemotaxis / drug effects
  • Chemotaxis / physiology*
  • Crk-Associated Substrate Protein
  • Cytoskeleton / drug effects
  • Cytoskeleton / ultrastructure
  • Enzyme Inhibitors / pharmacology
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • Humans
  • Jurkat Cells / cytology
  • Jurkat Cells / drug effects
  • Jurkat Cells / metabolism
  • Macromolecular Substances
  • Neoplasm Proteins / metabolism
  • Oncogene Proteins / metabolism*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphoproteins / metabolism*
  • Phosphorylation
  • Protein Binding / drug effects
  • Protein Processing, Post-Translational / drug effects
  • Protein-Tyrosine Kinases / metabolism*
  • Proteins / metabolism*
  • Receptors, CXCR4 / drug effects
  • Receptors, CXCR4 / physiology
  • Recombinant Proteins / pharmacology
  • Retinoblastoma-Like Protein p130
  • Signal Transduction / drug effects
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / metabolism
  • Wiskott-Aldrich Syndrome Protein

Substances

  • Actins
  • Adaptor Proteins, Signal Transducing
  • BCAR1 protein, human
  • Biopolymers
  • CXCL12 protein, human
  • Chemokine CXCL12
  • Chemokines, CXC
  • Crk-Associated Substrate Protein
  • Enzyme Inhibitors
  • Macromolecular Substances
  • Nck protein
  • Neoplasm Proteins
  • Oncogene Proteins
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphoproteins
  • Proteins
  • Receptors, CXCR4
  • Recombinant Proteins
  • Retinoblastoma-Like Protein p130
  • WAS protein, human
  • Wiskott-Aldrich Syndrome Protein
  • Protein-Tyrosine Kinases
  • Focal Adhesion Kinase 1
  • Focal Adhesion Protein-Tyrosine Kinases
  • PTK2 protein, human